Drugs / ATG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02707393 Background | Apr 2009 → Dec 2020 | chronic myeloid leukemia | St. Anna Children's Cancer Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02707393 ↗ |
| Route | Intravenous | “ATG intravenous” NCT02707393 ↗ |